Amgen's 2nd-qtr 2016 results top analysts' forecasts

28 July 2016
2019_biotech_test_vial_discovery_big

USA-based biotech giant Amgen (Nasdaq: AMGN) has reported second-quarter 2016 financial results which beat forecasts, posting a profit of $1.87 billion, a year-on-year rise of 13%.

The company reported revenue of $5.69 billion, up 5.9% in the reporting period, also exceeding the $5.6 billion of six analysts surveyed by Zacks Investment Research.

Amgen said earnings per share (EPS) on a generally-accepted accounting principles GAPP) basis were $2.47 for the quarter. Earnings, adjusted for non-recurring costs, were $2.84 per share. The results topped the average estimate of 11 analysts surveyed by Zacks was for earnings of $2.74 per share.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology